Pharvaris director plans sale of 8,667 shares

A Pharvaris N.V. director filed a Rule 144 notice to sell 8,667 common shares tied to a stock option exercise, following a recent 8,000-share sale.

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) reports that director Robert Howard Glassman has filed a notice to sell Pharvaris common shares under Rule 144. The planned sale covers 8,667 common shares, expected to be sold on September 15, 2026, in connection with a stock option exercise for cash through Morgan Stanley Smith Barney LLC.

The notice also lists a prior sale by Robert R. Glassman of 8,000 common shares on September 9, 2026 for total proceeds of $300,396.00.

Key Figures

Planned shares to be sold: 8,667 shares Recent shares sold: 8,000 shares Proceeds from recent sale: $300,396.00 +2 more

5 metrics

Planned shares to be sold 8,667 shares Common shares tied to stock option exercise expected to be sold on September 15, 2026

Recent shares sold 8,000 shares Common shares sold on September 9, 2026 during the past three months

Proceeds from recent sale $300,396.00 Total value of 8,000 common shares sold on September 9, 2026

Planned sale date September 15, 2026 Expected sale date for 8,667 common shares related to stock option exercise

Issuer Pharvaris N.V. Issuer of the common shares subject to the Rule 144 notice

Key Terms

Rule 144, Stock Option Exercise, Common, Securities To Be Sold

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Common | 09/15/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Common financial

"Common | Morgan Stanley Smith Barney LLC Executive Financial Services"

Securities To Be Sold financial

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction related to PHVS is disclosed in this Form 144?

The filing discloses that director Robert Howard Glassman plans to sell 8,667 Pharvaris N.V. common shares on September 15, 2026, in connection with a stock option exercise for cash through Morgan Stanley Smith Barney LLC.

How many Pharvaris (PHVS) shares has the director already sold recently?

The document lists a prior sale by Robert R. Glassman of 8,000 common shares of Pharvaris N.V. on September 9, 2026, with total proceeds of $300,396.00 during the past three months.

What is the total number of Pharvaris (PHVS) shares covered by recent and planned sales?

The notice shows 8,000 common shares sold on September 9, 2026 and an additional planned sale of 8,667 common shares on September 15, 2026, all relating to Pharvaris N.V. common stock.

Under which rule are the Pharvaris (PHVS) shares being sold?

The sales are being reported under Rule 144, which governs the resale of restricted and affiliate-held securities, including the planned sale of 8,667 Pharvaris N.V. common shares and the recent 8,000-share sale disclosed for the past three months.

Which broker is involved in the planned Pharvaris (PHVS) share sale?

The planned sale of 8,667 Pharvaris N.V. common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as stated in the disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 04:44 PM Accepted by SEC EDGAR 09/15/2026 - 04:43 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001897890
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PHARVARIS N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	31 (0)71 2036 410
Name of Person for Whose Account the Securities are To Be Sold	ROBERT GLASSMAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8667	331716.42	70204506	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2026	Stock Option Exercise	Issuer			8667	09/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROBERT R. GLASSMAN Emmy Noetherweg 2 Leiden P7 2333 BK	Common	09/09/2026	8000	300396.00

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Robert Howard Glassman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)